INIT — Initiator Pharma A/S Share News
0.000.00%
Last trade - 00:00- SEK195.09m
- SEK176.92m
Brief: Initiator Pharma Secures Bridge Financing Of SEK 5 Million
Brief: Initiator Pharma Q1 EBIT Loss DKK 1.5 Million
Brief: Initiator Pharma Q3 EBIT Loss Widens To DKK 3.7 Million
Brief: Initiator Pharma Signs Option Agreement For Phase 2 Ready Drug Candidate
Brief: Initiator Pharma Gets About SEK 12.7 Million Through Exercise Of Warrants And Directed Share Issue
Brief: Initiator Pharma Looking Forward To Proceed Phase 1 Trial
Brief: Initiator Pharma Q2 EBIT Was loss SEK 3,3 mln
Brief: Initiator Pharma Announces MHRA Approval For Clinical Trial
Brief: Initiator Pharma Q1 EBIT Loss Widens To DKK 3.1 Million
Brief: Initiator Pharma Raises About SEK 20.6 Million In Rights Issue
Brief: Initiator Pharma Reports Q4 EBIT Loss At DKK 3.9 Million
Brief: Initiator Pharma To Carry Out Issue With Proceeds Of About SEK 31.8 Mln Before Issuing Costs
Brief: Initiator Pharma Receives Intention To Grant Notice For Patent Application
Brief: Initiator Pharma Completes Preclinical Studies For Development Of Candidate IPED2015
Brief: Initiator Pharma Reports Positive Results From Toxicology Study
Brief: Initiator Pharma Q3 EBIT loss widens to DKK 2.5 mln
Brief: Initiator Pharma: positive results from toxicology study